Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Modern Chinese Medicine Group Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Modern Chinese Medicine Group Co OCF Yield % Related Terms
Modern Chinese Medicine Group Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Chinese Medicine Group Co OCF Yield % Chart
HKSE:01643 vs LLY, JNJ, ABBV: OCF Yield % Comparison
For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Chinese Medicine Group Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Modern Chinese Medicine Group Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Chinese Medicine Group Co (HKSE:01643) has a OCF Yield % of 0.59 as of Jul. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Modern Chinese Medicine Group Co and its competitors. This is 96% below median its historical median of 14.66. Over the past decade, Modern Chinese Medicine Group Co's OCF Yield % has ranged from 0.23 to 69.88. According to the industry distribution chart, Modern Chinese Medicine Group Co ranks #678 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 67.3%.
Is Modern Chinese Medicine Group Co's OCF Yield % too high?
Modern Chinese Medicine Group Co's current OCF Yield % of 0.59 is 96% below median its 10-year median of 14.66. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 69.88. The Drug Manufacturers industry median OCF Yield % is 3.59. Modern Chinese Medicine Group Co's value of 0.59 is 83.6% below this industry median. Based on the distribution chart, Modern Chinese Medicine Group Co ranks #678 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Modern Chinese Medicine Group Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Modern Chinese Medicine Group Co's OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Modern Chinese Medicine Group Co ranks #678 out of 1007 companies for OCF Yield %. This places Modern Chinese Medicine Group Co in the lower half of its industry. The industry median OCF Yield % is 3.59. Modern Chinese Medicine Group Co's value of 0.59 is 83.6% below this benchmark. Historically, Modern Chinese Medicine Group Co's own OCF Yield % has ranged from 0.23 to 69.88 over the past decade. While the company's 10-year median is 14.66 vs. the industry median of 3.59, Modern Chinese Medicine Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.59, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modern Chinese Medicine Group Co's current OCF Yield % of 0.59 is 83.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Modern Chinese Medicine Group Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Chinese Medicine Group Co's current OCF Yield % is 0.59, which is 96% below median its own 10-year median of 14.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Chinese Medicine Group Co stock overvalued right now?
Based on GuruFocus' analysis, Modern Chinese Medicine Group Co (HKSE:01643) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.94 — trading 487.5% above its estimated fair value. The current OCF Yield % is 0.59, which is 96% below median its 10-year median of 14.66 and 83.6% below the Drug Manufacturers industry median of 3.59. Modern Chinese Medicine Group Co's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Modern Chinese Medicine Group Co (HKSE:01643), the current OCF Yield % is 0.59 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Modern Chinese Medicine Group Co (HKSE:01643) Overvalued in 2026?
Based on GuruFocus' analysis, Modern Chinese Medicine Group Co stock appears to be overvalued.
The current stock price of HK$0.94 is trading 487.5% above its estimated GF Value™ of HK$0.16.
GuruFocus considers Modern Chinese Medicine Group Co to be Significantly Overvalued.
Key valuation signals for HKSE:01643:
OCF Yield %: 0.59 (96% below median its 10-year median of 14.66)
GF Value™: HK$0.16 vs. price of HK$0.94 (487.5% above fair value)
Industry Position: 83.6% below the Drug Manufacturers median (#678 of 1007)
No single metric tells the full story. See the HKSE:01643 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Modern Chinese Medicine Group Co Business Description
Modern Chinese Medicine Group Co Ltd is engaged in the production of Proprietary Chinese Medicines. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include liver protection tablets, Shanmei capsules, Qi and blood supplement pills, and Xiaohuoluo pills, among others. Geographically, the company derives its key revenue from the People's Republic of China.
53GF Score
Get the complete analysis for HKSE:01643
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01643 has been successfully added to your 
